Cumberland Pharmaceuticals Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$8,292	$10,837	$11,713	$10,435
Gross Profit	7,303	8,825	10,287	8,459
EBITDA	-795	699	2,734	46
EBIT	-1,833	-619	1,417	-1,735
Net Income	-1,940	-740	1,257	-1,903
Net Change In Cash	8,292	10,837	11,713	10,435
Free Cash Flow	163	817	3,850	1,877
Cash	15,196	16,087	15,108	17,964
Basic Shares	14,953	14,960	15,259	13,971

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$37,867	$39,552	$42,010	$35,985
Gross Profit	31,281	33,485	32,892	27,173
EBITDA	182	2,485	332	-857
EBIT	-5,860	-5,617	-4,995	-5,464
Net Income	-6,479	-6,279	-5,570	-3,507
Net Change In Cash	37,867	39,552	42,010	35,985
Free Cash Flow	-791	5,640	6,379	5,987
Cash	17,964	18,321	19,757	27,040
Basic Shares	14,060	14,298	14,563	14,904